• Download mobile app
09 Nov 2024, Edition - 3406, Saturday

Trending Now

  • If we join electoral alliances we will lose our individuality; Alliance in elections tantamounts to suicide – NTK leader Seeman
  • PDK President Krishnaswamy has welcomed the announcement of TVK leader Vijay that the coalition parties will be given a fair share in the governing power.
  • Last IPL season, even though I played as tail ender, the team was happy; I want to enjoy cricket for the next few years – MS Dhoni
  • I doubt if Adi Dravida Welfare Department is functioning in the DMK regime. – Opposition leader Edappadi Palaniswami
  • Adani Group Chairman Gautham Adani tops Indians with wealth gain in 2024; Gautam Adani’s net worth has increased to 9 lakh 75 thousand crore rupees, according to Forbes.
  • “I have failed many times in my cricket career; Gambhir and Surya Kumar Yadav believed in me and gave me a chance” – Sanju Samson

Businesswire

OptraSCAN® Receives CE Mark Approval for In-Vitro Diagnostics Use

by businesswireindia.com

Share
Business Wire India

OptraSCAN®, the leading end-to-end digital pathology solution provider, announced that their whole-slide scanners have received CE Mark approval for European Standards applicable to “In-Vitro Diagnostics Directive (IVDD)” 98/79/EC for in-vitro diagnostics use. The CE Mark will allow OptraSCAN’s scanners to be sold in countries belonging to or affiliated to European Union (EU) that recognizes CE Mark.

 

OptraSCAN’s On-Demand desktop scanning systems are cloud-enabled and provide the ultimate flexibility for storing, archiving and managing digital images and metadata. These small footprint, low and high throughput scanners are fully-integrated, affordable and lightweight that can easily fit into small workspaces.

 

“The CE Mark specifically addresses the safety, quality and performance of In-Vitro Diagnostic Directives (IVDDs) (98/79/EC), and certifies that it has been created and manufactured to meet strict safety and health criteria for distribution in the European Union (EU). We are very pleased to receive this approval as it underlines our commitment in providing robust, high-quality solutions to meet the needs of diverse healthcare providers in the EU and affiliated countries,” said Abhi Gholap, Founder & CEO.

 

He further added, “This is a significant milestone for OptraSCAN to support pathologists from the European continent towards adopting Digital Pathology for their requirements.”

 

About OptraSCAN:

 

OptraSCAN® (www.optrascan.com), ISO 13485 certified, is an end-to-end digital pathology solution provider. OptraSCAN is focused on delivering fully integrated, affordable solutions that will maximize your return on investment and improve the performance of your pathology services. OptraSCAN® is a pioneer in the On-Demand Digital Pathology® System and is working to eliminate the barriers to “Go Digital” no matter the size of the pathology lab, the lab's throughput or global location.

 

OptraSCAN’s end-to-end solution provides effective acquisition of whole slide images, viewing, storing, sharing, reporting, analysis and management of digital slides and associated metadata, via On-Demand solution or outright purchase model. Follow us on LinkedIn and Twitter.

 

 
Source: Businesswire
COIMBATORE WEATHER